On August 26, 2025 BioInvent reported interim report for the period January to June 2025 (Presentation, BioInvent, AUG 26, 2025, https://www.bioinvent.com/sites/bioinvent/files/pr/20250826-b8958ea1-a830-41b4-871e-759ffd4abac0-1.pdf?ts=1756189813 [SID1234656794]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!